Japanese Pharmaceutical Stocks Slide as TrumpRx.gov Launch Sparks Market Concerns 
Gold and Silver Prices Rebound After Volatile Week Triggered by Fed Nomination 
South Africa Eyes ECB Repo Lines as Inflation Eases and Rate Cuts Loom 
Trump’s Inflation Claims Clash With Voters’ Cost-of-Living Reality 
UK Starting Salaries See Strongest Growth in 18 Months as Hiring Sentiment Improves 
Global Markets Slide as AI, Crypto, and Precious Metals Face Heightened Volatility 
Japan Economy Poised for Q4 2025 Growth as Investment and Consumption Hold Firm 
Australian Pension Funds Boost Currency Hedging as Aussie Dollar Strengthens 
Oil Prices Slip as U.S.-Iran Talks Ease Middle East Tensions 
Trump Lifts 25% Tariff on Indian Goods in Strategic U.S.–India Trade and Energy Deal 
Nikkei 225 Hits Record High Above 56,000 After Japan Election Boosts Market Confidence 
Russian Stocks End Mixed as MOEX Index Closes Flat Amid Commodity Strength 
Asian Currencies Stay Rangebound as Yen Firms on Intervention Talk 
Asian Stocks Slip as Tech Rout Deepens, Japan Steadies Ahead of Election 
Dollar Near Two-Week High as Stock Rout, AI Concerns and Global Events Drive Market Volatility 
South Korea exported US$1.69 billion worth of pharmaceuticals, cosmetics, and medical devices in August, up 42 percent from a year ago.
According to data from the Korea Health Industry Development Institute (KHIDI), the exports got a big lift from the growing demand for COVID-19-related medical devices.
The country exported $660 million worth of medicines, up 70.9 percent from a year ago, while medical devices exports rose 51.7 percent to $430 million. Cosmetics exports were up 15.6 percent to $599 million.
The increase in exports was for the 12th consecutive month since September last year.
China made the most importation for such products, followed by Germany, the US, and Japan.
The KHDI expects annual exports of South Korea's healthcare industry to reach about $20 billion if the trend continues.
